14-3-3theta Protects against Neurotoxicity in a Cellular Parkinson's Disease Model through Inhibition of the Apoptotic Factor Bax

Phosphorylation-Dependent 14-3-3 Binding to LRRK2 Is Impaired by Common Mutations of Familial Parkinson's Disease

(2011) Xianting Li et al.   PLoS One

Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910/Ser935, disruption of 14-3-3 binding and altered cytoplasmic localization

(2010) Nicolas Dzamko et al.   BIOCHEMICAL JOURNAL

14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization

(2010) R. Jeremy Nichols et al.   BIOCHEMICAL JOURNAL

Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease

(2010) T A Yacoubian et al.   Cell Death & Disease

Occupation and Risk of Parkinsonism

(2009) Caroline M. Tanner et al.   ARCHIVES OF NEUROLOGY

Bax shuttling after rotenone treatment of neuronal primary cultures: Effects on cell death phenotypes

(2009) Martin B. Gill et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Targets for neuroprotection in Parkinson's disease

(2008) Talene A. Yacoubian et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Kynurenic acid attenuates MPP+-induced dopaminergic neuronal cell death via a Bax-mediated mitochondrial pathway

(2008) Do Yeon Lee et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

Transcriptional dysregulation in a transgenic model of Parkinson disease

(2007) Talene A. Yacoubian et al.   NEUROBIOLOGY OF DISEASE